CVD & Stroke: Understanding the relation and impact on risk managementOct. 14, 2016 - Moscow, Russia - David Waters, MD – San Francisco, USA - CVRMC 2016, Russia
Lecture held by David Waters, MD – University of California, San Francisco, USA, during the CV Risk Master Class held on October 14-15, 2016 in Moscow, Russia
The overall educational objectives of the Cardiovascular Master Class were to:
- review the epidemiology and current guidelines on the diagnosis, management, and treatment of patients at increased CV risk in Russia
- review new data on the pathophysiology of coronary artery disease and stroke and its relevance to treatment strategies and outcomes
- understand the medical need for intensive lipid and hypertension management in patients at high CV risk, such as DM and metabolic syndrome.
- understand the pharmacologic and clinical rationale for various treatment options in the patients with increased CV risk and integrate scientific evidence from key clinical trials into clinical practice
- Develop a consensus on practical guidelines for day-to-day management of high risk patients.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of Russian Ministry of Health (Order # 82 from 18.02.2013) through the providership of Russian Cardiology Society and Russian CME Botkin Society is accredited by the the Coordination Council for Continuing Medical and Pharmaceutical to provide continuing medical education for physicians, granting 9 credits.
*Dr. David D. Waters* is Emeritus Professor in the Department of Medicine at the University of California, San Francisco. He was Chief of Cardiology at San Francisco General Hospital and the Maurice Eliaser Jr. Distinguished Professor of Medicine at UCSF from 1999 to 2007.
The conference was sponsored by an unrestricted educational grant provided by Pfizer Europe